Correlation Between Pfizer and Cellectar Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Cellectar Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Cellectar Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Cellectar Biosciences, you can compare the effects of market volatilities on Pfizer and Cellectar Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Cellectar Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Cellectar Biosciences.

Diversification Opportunities for Pfizer and Cellectar Biosciences

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between Pfizer and Cellectar is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Cellectar Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cellectar Biosciences and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Cellectar Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cellectar Biosciences has no effect on the direction of Pfizer i.e., Pfizer and Cellectar Biosciences go up and down completely randomly.

Pair Corralation between Pfizer and Cellectar Biosciences

Considering the 90-day investment horizon Pfizer Inc is expected to generate 0.58 times more return on investment than Cellectar Biosciences. However, Pfizer Inc is 1.74 times less risky than Cellectar Biosciences. It trades about -0.26 of its potential returns per unit of risk. Cellectar Biosciences is currently generating about -0.42 per unit of risk. If you would invest  2,842  in Pfizer Inc on August 28, 2024 and sell it today you would lose (265.00) from holding Pfizer Inc or give up 9.32% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  Cellectar Biosciences

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
Cellectar Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cellectar Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Pfizer and Cellectar Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Cellectar Biosciences

The main advantage of trading using opposite Pfizer and Cellectar Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Cellectar Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cellectar Biosciences will offset losses from the drop in Cellectar Biosciences' long position.
The idea behind Pfizer Inc and Cellectar Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Bonds Directory
Find actively traded corporate debentures issued by US companies
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.